Pemetrexed clinical studies in performance status 2 patients with non-small cell lung cancer (Review)

Because poor performance status (PS) is an independent prognostic factor in non-small cell lung cancer (NSCLC), PS scores are widely used by oncologists to make treatment decisions. Advanced NSCLC patients with an Eastern Cooperative Oncology Group PS of 2 have poor prognoses and are frequently excl...

Descripción completa

Detalles Bibliográficos
Autores principales: ZINNER, RALPH, GRUL, CARLA VISSEREN, SPIGEL, DAVID R., OBASAJU, COLEMAN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4734604/
https://www.ncbi.nlm.nih.gov/pubmed/26530033
http://dx.doi.org/10.3892/ijo.2015.3219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4734604/
https://www.ncbi.nlm.nih.gov/pubmed/26530033
http://dx.doi.org/10.3892/ijo.2015.3219

Ejemplares similares